123 related articles for article (PubMed ID: 1800462)
1. The effects of glutathione depletion on the biodistribution of Cu(PTSM) in rats.
Barnhart-Bott A; Green MA
Int J Rad Appl Instrum B; 1991; 18(8):865-9. PubMed ID: 1800462
[TBL] [Abstract][Full Text] [Related]
2. Effects of ischemia-reperfusion injury on myocardial single pass extraction and retention of Cu-PTSM in perfused rat hearts: comparison with 201T1 and 14C-iodoantipyrine.
Wada K; Fujibayashi Y; Taniuchi H; Tajima N; Tamaki N; Konishi J; Yokoyama A
Nucl Med Biol; 1994 May; 21(4):613-7. PubMed ID: 9234318
[TBL] [Abstract][Full Text] [Related]
3. Subcellular distribution of tissue radiocopper following intravenous administration of 67Cu-labeled Cu-PTSM.
Baerga ID; Maickel RP; Green MA
Int J Rad Appl Instrum B; 1992 Aug; 19(6):697-701. PubMed ID: 1522024
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships for metal-labeled blood flow tracers: comparison of keto aldehyde bis(thiosemicarbazonato)copper(II) derivatives.
John EK; Green MA
J Med Chem; 1990 Jun; 33(6):1764-70. PubMed ID: 2342070
[TBL] [Abstract][Full Text] [Related]
5. Human biodistribution and dosimetry of the PET perfusion agent copper-62-PTSM.
Wallhaus TR; Lacy J; Whang J; Green MA; Nickles RJ; Stone CK
J Nucl Med; 1998 Nov; 39(11):1958-64. PubMed ID: 9829589
[TBL] [Abstract][Full Text] [Related]
6. Copper(II) bis(thiosemicarbazone) complexes as potential tracers for evaluation of cerebral and myocardial blood flow with PET.
Green MA; Klippenstein DL; Tennison JR
J Nucl Med; 1988 Sep; 29(9):1549-57. PubMed ID: 3261785
[TBL] [Abstract][Full Text] [Related]
7. Species-dependent binding of copper(II) bis(thiosemicarbazone) radiopharmaceuticals to serum albumin.
Mathias CJ; Bergmann SR; Green MA
J Nucl Med; 1995 Aug; 36(8):1451-5. PubMed ID: 7629593
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria-selective reduction of 62Cu-pyruvaldehyde bis(N4-methylthiosemicarbazone) (62Cu-PTSM) in the murine brain; a novel radiopharmaceutical for brain positron emission tomography (PET) imaging.
Fujibayashi Y; Wada K; Taniuchi H; Yonekura Y; Konishi J; Yokoyama A
Biol Pharm Bull; 1993 Feb; 16(2):146-9. PubMed ID: 8395929
[TBL] [Abstract][Full Text] [Related]
9. Application of the new zinc-62/copper-62 generator: an effective labeling method for 62Cu-PTSM.
Matsumoto K; Fujibayashi Y; Yonekura Y; Wada K; Takemura Y; Konishi J; Yokoyama A
Int J Rad Appl Instrum B; 1992 Jan; 19(1):39-44. PubMed ID: 1577613
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a potential generator-produced PET tracer for cerebral perfusion imaging: single-pass cerebral extraction measurements and imaging with radiolabeled Cu-PTSM.
Mathias CJ; Welch MJ; Raichle ME; Mintun MA; Lich LL; McGuire AH; Zinn KR; John EK; Green MA
J Nucl Med; 1990 Mar; 31(3):351-9. PubMed ID: 2308007
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cell-labeling methods with ¹²⁴I-FIAU and ⁶⁴Cu-PTSM for cell tracking using chronic myelogenous leukemia cells expressing HSV1-tk and firefly luciferase.
Park JJ; Lee TS; Son JJ; Chun KS; Song IH; Park YS; Kim KI; Lee YJ; Kang JH
Cancer Biother Radiopharm; 2012 Dec; 27(10):719-28. PubMed ID: 23009582
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a solvent extraction technique for determination of Cu-PTSM in blood.
Mathias CJ; Bergmann SR; Green MA
Nucl Med Biol; 1993 Apr; 20(3):343-9. PubMed ID: 8485494
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) for tissue blood flow measurement using a trapped tracer model.
Young H; Carnochan P; Zweit J; Babich J; Cherry S; Ott R
Eur J Nucl Med; 1994 Apr; 21(4):336-41. PubMed ID: 8005157
[TBL] [Abstract][Full Text] [Related]
14. Clinical application and quantitative evaluation of generator-produced copper-62-PTSM as a brain perfusion tracer for PET.
Okazawa H; Yonekura Y; Fujibayashi Y; Nishizawa S; Magata Y; Ishizu K; Tanaka F; Tsuchida T; Tamaki N; Konishi J
J Nucl Med; 1994 Dec; 35(12):1910-5. PubMed ID: 7989968
[TBL] [Abstract][Full Text] [Related]
15. A potential copper radiopharmaceutical for imaging the heart and brain: copper-labeled pyruvaldehyde bis(N4-methylthiosemicarbazone).
Green MA
Int J Rad Appl Instrum B; 1987; 14(1):59-61. PubMed ID: 3583756
[TBL] [Abstract][Full Text] [Related]
16. Tissue blood flow estimation with copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) and PET.
Young H; Carnochan P; Zweit J; Babich J; Cherry S; Ott R
J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):89-91. PubMed ID: 7632775
[TBL] [Abstract][Full Text] [Related]
17. Retention of the radiotracers 64Cu-ATSM and 64Cu-PTSM in human and murine tumors is influenced by MDR1 protein expression.
Liu J; Hajibeigi A; Ren G; Lin M; Siyambalapitiyage W; Liu Z; Simpson E; Parkey RW; Sun X; Oz OK
J Nucl Med; 2009 Aug; 50(8):1332-9. PubMed ID: 19617332
[TBL] [Abstract][Full Text] [Related]
18. Production and tumour uptake of [64Cu]Pyruvaldehyde-bis (N4-methylthiosemicarbazone) for PET and/or therapeutic purposes.
Jalilian AR; Rowshanfarzad P; Kamrani YY; Shafaii K; Mirzaii M
Nucl Med Rev Cent East Eur; 2007; 10(1):6-11. PubMed ID: 17694494
[TBL] [Abstract][Full Text] [Related]
19. Changes in regional brain perfusion during functional brain activation: comparison of [(64)Cu]-PTSM with [(14)C]-Iodoantipyrine.
Holschneider DP; Yang J; Sadler TR; Galifianakis NB; Bozorgzadeh MH; Bading JR; Conti PS; Maarek JM
Brain Res; 2008 Oct; 1234():32-43. PubMed ID: 18687316
[TBL] [Abstract][Full Text] [Related]
20. Differential mechanism of retention of Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM) by brain and tumor: a novel radiopharmaceutical for positron emission tomography imaging.
Fujibayashi Y; Taniuchi H; Wada K; Yonekura Y; Konishi J; Yokoyama A
Ann Nucl Med; 1995 Feb; 9(1):1-5. PubMed ID: 7779524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
